Charlotte Verbeke

Charlotte Verbeke

Auto-generated profile, based on publicly available information

Charlotte Verbeke

Affiliation Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
ESElise Schoefs
Elise Schoefs
CVCharlotte Verbeke
Charlotte Verbeke
JBJolien Broekmans
Jolien Broekmans
SSSilène Ten Seldam
Silène Ten Seldam
KMKate Morgan
Kate Morgan
IHIsabelle Huys
Isabelle Huys
Shared decision making (SDM) is highly relevant in oncology and cancer care, yet its application within multiple myeloma (MM) remains underexplored. This s

31 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
CVCharlotte Verbeke
Charlotte Verbeke
FSFiene Schuermans
Fiene Schuermans
FVFien Vanopré
Fien Vanopré
ABAline Belmans
Aline Belmans
MHMaxime Van Houdt
Maxime Van Houdt
IHIsabelle Huys
Isabelle Huys
Background: Breast cancer is one of the most common cancers worldwide, with both the disease and the treatments affecting patients’ quality of life and overall survival. Patient preference studies can help to identify what matters most to patients. This study aims to provide an overview of published patient preference studies in breast cancer, focusing on (i) the design of the study, (ii) preference outcomes including preference heterogeneity, (iii) recruitment strategies, and (iv) patient involvement. Methods: For this scoping review, a search strategy was created for five databases (PubMed, Embase, Scopus, Web of Science Core Collection, and CINAHL), based on the concepts ‘breast cancer’ and ‘patient preference’. The articles were screened double-blind in two phases, after which, the relevant data was extracted and analyzed. Results: A total of 31 articles were selected based on the eligibility criteria. The studies were published over a wide time range (1995–2024), and across different countries. Different methodologies were used, and different attributes were included, mainly related to adverse events of treatments and survival elements. Survival elements were almost always considered important when included. Preference heterogeneity was assessed in 24 of the included studies. The involvement of patients in these studies varied; in two studies, patients were involved in an advisory board; in five studies, patients provided feedback on the preference study conduct via interviews or focus group discussions; and in twelve studies, pilot tests were mentioned. Conclusions: The studies show diverse methods, outcomes, and patient involvement strategies. This may complicate the implementation of preferences in decision-making, suggesting preference studies with clear objectives and implementation strategies to create impact for and with patients.

28 August 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJolien Broekmans
Jolien Broekmans
ESElise Schoefs
Elise Schoefs
CVCharlotte Verbeke
Charlotte Verbeke
LPLien De Proost
Lien De Proost
SSSilène Ten Seldam
Silène Ten Seldam
IHIsabelle Huys
Isabelle Huys
Background: Multiple myeloma (MM) is characterized by complex and evolving treatment pathways, involving multiple preference-sensitive decisions across the disease trajectory. Shared decision-making (SDM) is widely recognized as a best-practice approach for such decisions, yet practical, context-specific guidance for implementing SDM in MM care remains limited. Objective: To develop a set of practical, stakeholder-informed recommendations to support the implementation of SDM in MM care. Methods: This study was conducted as part of a European mixed-methods research project initiated by the patient organization Myeloma Patients Europe. Building on empirical studies involving MM patients and healthcare professionals (HCPs), an initial set of 24 recommendations was developed. These recommendations were subsequently refined, and agreed upon through two online multi-stakeholder workshops, involving patients, carers, hematologists, oncology nurses, and patient organization representatives from multiple European countries. Qualitative workshop data were thematically analyzed, and recommendations were consolidated through iterative team discussions. Results: The final output comprises ten core recommendations addressing SDM implementation at multiple levels. Key themes included in the recommendations are adopting a personalized and preference-sensitive approach to patient involvement, tailoring information provision, openly discussing all treatment options including no treatment, strengthening multidisciplinary communication, supporting patient preparation and partnership, ensuring continuity of care, and providing structural, educational, and organizational support for SDM. Conclusions: These recommendations translate SDM principles into guiding considerations tailored to the specific challenges of MM care. They provide a foundation for context-sensitive implementation efforts aimed at strengthening patient-centered decision-making in MM.

28 August 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CVCharlotte Verbeke
Charlotte Verbeke
JBJolien Broekmans
Jolien Broekmans
ESElise Schoefs
Elise Schoefs
SSSilène Ten Seldam
Silène Ten Seldam
KMKate Morgan
Kate Morgan
IHIsabelle Huys
Isabelle Huys
Introduction: Shared decision-making (SDM) can enhance patient involvement in treatment and care decisions. Still, questions remain on how multiple myeloma (MM) patients perceive and evaluate their current and desired roles in these decisions and whether characteristics influence their willingness to be involved. This study aimed to identify I) the current knowledge of the concept SDM among MM patients and healthcare professionals (HCPs) involved in MM care, II) how MM patients are and want to be involved in decisions, and III) differences in the willingness to be involved in view of participants’ characteristics (e.g., age, gender, health literacy). Methods: An online survey for MM patients and HCPs involved in MM care was launched in October and December 2023, respectively. The data was statistically analyzed. Results: 558 patients and 89 HCPs completed the survey. Most patients lived in the Netherlands (28.7%), Israel (23.5%) and Belgium (15.8%), and most HCPs lived in France (39.3%) and Israel (24.7%). 56.6% of the patients and 28.1% of the HCPs had not previously heard of SDM. Almost all patients (96.1%) indicated wanting to be involved in treatment decisions. 3.9% of patients indicated not wanting to be involved, because they did not know whether they would have enough knowledge to decide or because they were used to the HCP deciding. All HCPs believed that MM patients should be involved if they want to. Patients had higher involvement scores at recent consultations and desired to be more involved in initial decisions following diagnosis. The survey revealed no significant differences in participants’ involvement and their characteristics. Conclusion: MM patients want to be involved in decisions and HCPs are willing to involve MM patients. However, challenges remain concerning the practical implementation of involvement and SDM. This highlights the importance of understanding SDM and patient involvement and assessing the individual needs and preferences of MM patients.

20 January 2026 in Perspectives on Medical Education
Verified
Journal Article
Open access
PDF file
MBMatthijs H. Bosveld
Matthijs H. Bosveld
DMDante N. Mulder
Dante N. Mulder
LGLucija Gosak
Lucija Gosak
IHIsabelle Huys
Isabelle Huys
CKCathy C. Kline
Cathy C. Kline
RFRicardo J. O. Ferreira
Ricardo J. O. Ferreira
Introduction: The combination of patient and public involvement (PPI) and interprofessional education (IPE) is promising to help students delineate roles based on real patients’ needs; however, their integration in practice remains limited. Although the individual concepts have been studied, little is known about how stakeholders perceive PPI in IPE, leaving gaps in designing effective educational strategies. Therefore, this study aims to explore the experiences and perspectives of key stakeholders – students, academic staff members, and patient representatives – on the feasibility, (intended) learning outcomes, and requirements for the successful implementation of PPI in IPE in undergraduate healthcare education.Methods: We qualitatively explored the experiences and perspectives of each stakeholder group in separate focus groups. In total, 15 focus groups were conducted across four European countries, involving 27 academic staff members, 27 students, and 24 patient representatives, all with diverse backgrounds. Data were analyzed using thematic analysis.Results: Themes were structured by organizational levels within educational institutions to optimize uptake in practice. As for strategic considerations (align), participants noted compounded organizational complexity, which may lead to inertia – especially without institutional support. At the same time, PPI in IPE should be valued equally compared to biomedical subjects. With respect to educational design considerations, PPI in IPE helped students bridge theory and practice and decreased hierarchy. Lastly, regarding operational considerations (execute), the compounding complexity of organizing patient involvement in interprofessional education also holds true for facilitating it, as facilitators must role-model both person-centered communication and interprofessional collaboration. According to participants, learning from PPI in IPE is about unifying what cannot be separated.Discussion: Despite strong rhetorical endorsement, a lack of institutional support persists. Our findings suggest PPI in IPE as a powerful means of addressing epistemic injustice by promoting epistemic symmetry between future professionals and patients, reducing interprofessional hierarchies, and grounding interprofessional learning in real-world experiences. Strategic use of these levers may unlock the necessary institutional resources, acting as Alexander’s sword to overcome barriers and ultimately slice through the Gordian knot.